BACKGROUND: HIV/AIDS has orphaned 11.6 million children in sub-Saharan Africa. Expanded antiretroviral therapy (ART) use may reduce AIDS orphanhood by decreasing adult mortality and population-level HIV transmission. METHODS: We modeled two scenarios to measure the impact of adult ART use on the incidence of orphanhood in 10 sub-Saharan African countries, from 2009 to 2020. Demographic model data inputs were obtained from cohort studies, UNAIDS, UN Population Division, WHO and the US Census Bureau. RESULTS: Compared to current rates of ART uptake, universal ART access averted 4.37 million more AIDS orphans by year 2020, including 3.15 million maternal, 1.89 million paternal and 0.75 million double orphans. The number of AIDS orphans averted was highest in South Africa (901.71 thousand) and Nigeria (839.01 thousand), and lowest in Zimbabwe (86.96 thousand) and Côte d'Ivoire (109.12 thousand). CONCLUSION: Universal ART use may significantly reduce orphanhood in sub-Saharan Africa.
BACKGROUND: HIV/AIDS has orphaned 11.6 million children in sub-Saharan Africa. Expanded antiretroviral therapy (ART) use may reduce AIDS orphanhood by decreasing adult mortality and population-level HIV transmission. METHODS: We modeled two scenarios to measure the impact of adult ART use on the incidence of orphanhood in 10 sub-Saharan African countries, from 2009 to 2020. Demographic model data inputs were obtained from cohort studies, UNAIDS, UN Population Division, WHO and the US Census Bureau. RESULTS: Compared to current rates of ART uptake, universal ART access averted 4.37 million more AIDS orphans by year 2020, including 3.15 million maternal, 1.89 million paternal and 0.75 million double orphans. The number of AIDS orphans averted was highest in South Africa (901.71 thousand) and Nigeria (839.01 thousand), and lowest in Zimbabwe (86.96 thousand) and Côte d'Ivoire (109.12 thousand). CONCLUSION: Universal ART use may significantly reduce orphanhood in sub-Saharan Africa.
Authors: Julio S G Montaner; Robert Hogg; Evan Wood; Thomas Kerr; Mark Tyndall; Adrian R Levy; P Richard Harrigan Journal: Lancet Date: 2006-08-05 Impact factor: 79.321
Authors: Viviane D Lima; Richard Harrigan; David R Bangsberg; Robert S Hogg; Robert Gross; Benita Yip; Julio S G Montaner Journal: J Acquir Immune Defic Syndr Date: 2009-04-15 Impact factor: 3.731
Authors: Fredrick E Makumbi; Gertrude Nakigozi; Joseph Sekasanvu; Ivan Lukabwe; Joseph Kagaayi; Tom Lutalo; Maria Wawer; Ronald Gray Journal: Trop Med Int Health Date: 2012-06-21 Impact factor: 2.622
Authors: Rebecca Marie Zash; Sajini Souda; Jean Leidner; Kelebogile Binda; Chazha Hick; Kathleen Powis; Joseph Makhema; Mompati Mmalane; Max Essex; Shahin Lockman; Roger L Shapiro Journal: AIDS Patient Care STDS Date: 2017-01 Impact factor: 5.078
Authors: Veronica C Lee; Patrick Muriithi; Ulrike Gilbert-Nandra; Andrea A Kim; Mary E Schmitz; James Odek; Rose Mokaya; Jennifer S Galbraith Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Reuben Granich; Somya Gupta; Amitabh B Suthar; Caoimhe Smyth; David Hoos; Marco Vitoria; Mariangela Simao; Catherine Hankins; Bernard Schwartlander; Renee Ridzon; Brigitte Bazin; Brian Williams; Ying-Ru Lo; Craig McClure; Julio Montaner; Gottfried Hirnschall Journal: Curr HIV Res Date: 2011-09 Impact factor: 1.581
Authors: Maria N Pyra; Jessica E Haberer; Nina Hasen; Jason Reed; Nelly R Mugo; Jared M Baeten Journal: J Int AIDS Soc Date: 2019-08 Impact factor: 5.396
Authors: Amitabh B Suthar; Nathan Ford; Pamela J Bachanas; Vincent J Wong; Jay S Rajan; Alex K Saltzman; Olawale Ajose; Ade O Fakoya; Reuben M Granich; Eyerusalem K Negussie; Rachel C Baggaley Journal: PLoS Med Date: 2013-08-13 Impact factor: 11.069